News

New FDA chief offers support for Kennedy on autism claims, says no more ‘mass cuts’ planned
US Food and Drug Administration Commissioner Dr. Marty Makary suggested in a new interview that autism is caused by a range ...
FDA making plans to end its routine food safety inspections, sources say
Food safety inspections would be left to state and local authorities under the plan being developed by the FDA.
US FDA limits industry employees from roles in its advisory committees
U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to limit employees of companies ...
FDA suspends food safety quality checks. How to protect yourself from salmonella, listeria
According to Reuters, the FDA is suspending a quality control program, for food testing labs. Here are the steps you should take to protect yourself.
STAT1d
Makary says FDA will remove pharma representatives from advisory panels
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them ...
US FDA suspends food safety quality checks after staff cuts
The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of ...
FDA hiring contractors to replace fired staff who supported safety inspections
The Food and Drug Administration is scrambling to hire contractors to replace fired employees who helped plan thousands of ...
FDA Clears Neuralink Rival’s Brain Implant
The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...
Medscape19h
FDA Authorizes First Prescription Digital Therapeutic for Migraine
The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
Drug Development Is Slowing Down After Cuts at the FDA
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.